CRISPR technologies for the treatment of Duchenne muscular dystrophy

The emerging clustered regularly interspaced short palindromic repeats (CRISPR)-mediated genome editing technologies have progressed remarkably in recent years, opening up the potential of precise genome editing as a therapeutic approach to treat various diseases. The CRISPR-CRISPR-associated (Cas)...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Eunyoung, Koo, Taeyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571109/
https://www.ncbi.nlm.nih.gov/pubmed/33823301
http://dx.doi.org/10.1016/j.ymthe.2021.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571109/
https://www.ncbi.nlm.nih.gov/pubmed/33823301
http://dx.doi.org/10.1016/j.ymthe.2021.04.002

Ejemplares similares